CCMINC
NVO

Cardinal Capital Management Inc (North Carolina)’s Novo Nordisk NVO Stock Holding History

Cardinal Capital Management Inc (North Carolina)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Buy
50,261
+3,568
+8% +$153K 0.29% 94
2026
Q1 		$1.77M Buy
46,693
+1,383
+3% +$65.5K 0.23% 106
2025
Q4 		$2.31M Sell
45,310
-5,318
-11% -$272K 0.31% 92
2025
Q3 		$2.81M Buy
50,628
+1,052
+2% +$61.6K 0.39% 81
2025
Q2 		$3.42M Buy
49,576
+1,161
+2% +$79K 0.5% 65
2025
Q1 		$3.42M Buy
48,415
+14
+0% +$1.16K 0.53% 66
2024
Q4 		$4.16M Buy
48,401
+143
+0.3% +$15.5K 0.65% 55
2024
Q3 		$5.75M Sell
48,258
-54
-0.1% -$7.2K 0.89% 39
2024
Q2 		$6.9M Sell
48,312
-20,417
-30% -$2.71M 1.16% 28
2024
Q1 		$8.89M Buy
68,729
+1,422
+2% +$169K 1.45% 21
2023
Q4 		$6.96M Sell
67,307
-772
-1% -$76.3K 1.32% 24
2023
Q3 		$6.19M Buy
68,079
+253
+0.4% +$22.3K 1.26% 26
2023
Q2 		$5.49M Sell
67,826
-1,072
-2% -$87.6K 1.11% 32
2023
Q1 		$5.52M Sell
68,898
-788
-1% -$55.9K 1.15% 34
2022
Q4 		$4.72M Sell
69,686
-1,064
-2% -$62.4K 1% 37
2022
Q3 		$3.52M Sell
70,750
-1,178
-2% -$63.1K 0.83% 45
2022
Q2 		$4.01M Buy
71,928
+128
+0.2% +$7.1K 0.92% 43
2022
Q1 		$3.99M Buy
71,800
+1,456
+2% +$74.7K 0.81% 47
2021
Q4 		$3.94M Sell
70,344
-448
-0.6% -$24.3K 0.78% 49
2021
Q3 		$3.4M Sell
70,792
-462
-0.6% -$22.3K 0.74% 47
2021
Q2 		$2.98M Buy
71,254
+512
+0.7% +$19.8K 0.63% 57
2021
Q1 		$2.38M Buy
70,742
+702
+1% +$25K 0.53% 65
2020
Q4 		$2.45M Buy
70,040
+962
+1% +$33.3K 0.58% 60
2020
Q3 		$2.4M Buy
69,078
+132
+0.2% +$4.4K 0.66% 54
2020
Q2 		$2.26M Sell
68,946
-10,738
-13% -$343K 0.65% 54
2020
Q1 		$2.4M Sell
79,684
-1,026
-1% -$30.5K 0.79% 46
2019
Q4 		$2.34M Sell
80,710
-610
-0.8% -$16.9K 0.61% 55
2019
Q3 		$2.1M Buy
81,320
+90
+0.1% +$2.28K 0.58% 57
2019
Q2 		$2.07M Sell
81,230
-1,354
-2% -$33.5K 0.59% 57
2019
Q1 		$2.16M Buy
82,584
+472
+0.6% +$11.6K 0.62% 56
2018
Q4 		$1.89M Buy
82,112
+1,576
+2% +$35K 0.62% 58
2018
Q3 		$1.9M Buy
80,536
+400
+0.5% +$9.76K 0.54% 65
2018
Q2 		$1.85M Buy
80,136
+1,350
+2% +$32.1K 0.56% 65
2018
Q1 		$1.94M Buy
78,786
+400
+0.5% +$10.5K 0.61% 61
2017
Q4 		$2.1M Buy
78,386
+548
+0.7% +$13.9K 0.64% 58
2017
Q3 		$1.87M Buy
77,838
+7,752
+11% +$175K 0.59% 63
2017
Q2 		$1.5M Buy
70,086
+14,986
+27% +$302K 0.5% 64
2017
Q1 		$944K Hold
55,100
– – 0.34% 78
2016
Q4 		$988K Buy
+55,100
New +$999K 0.38% 75

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina)'s NVO Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) increased its Novo Nordisk (NVO) stake by 7.6% in Q2 2026, buying an estimated $153K and bringing the position to 50,261 shares worth $2.41M. The position accounts for 0.29% of the portfolio, ranked #94.

Cardinal Capital Management Inc (North Carolina) first reported a position in NVO in Q4 2016 and has held it in 39 quarters since. The position peaked at $8.89M in Q1 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 50,261 shares of Novo Nordisk worth $2.41M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) bought 3,568 Novo Nordisk shares in Q2 2026, an estimated $153K.
  • Novo Nordisk made up 0.29% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #94 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Novo Nordisk in Q4 2016 and has held it in 39 quarters since.
  • Cardinal Capital Management Inc (North Carolina)'s Novo Nordisk position peaked at $8.89M in Q1 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.